Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
Terry Kenakin, Laurence J. Miller
Pharmacological Reviews (2010) Vol. 62, Iss. 2, pp. 265-304
Open Access | Times Cited: 559

Showing 1-25 of 559 citing articles:

The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean‐Martin Beaulieu, Raul R. Gainetdinov
Pharmacological Reviews (2011) Vol. 63, Iss. 1, pp. 182-217
Closed Access | Times Cited: 2474
How were new medicines discovered?
David C. Swinney, Jason Anthony
Nature Reviews Drug Discovery (2011) Vol. 10, Iss. 7, pp. 507-519
Closed Access | Times Cited: 1690
Structure-Function of the G Protein–Coupled Receptor Superfamily
Vsevolod Katritch, Vadim Cherezov, Raymond C. Stevens
The Annual Review of Pharmacology and Toxicology (2012) Vol. 53, Iss. 1, pp. 531-556
Open Access | Times Cited: 992
The Current State of Peptide Drug Discovery: Back to the Future?
Antoine Henninot, James C. Collins, John M. Nuss
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 4, pp. 1382-1414
Closed Access | Times Cited: 939
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin, Arthur Christopoulos
Nature Reviews Drug Discovery (2012) Vol. 12, Iss. 3, pp. 205-216
Open Access | Times Cited: 684
Allostery in Disease and in Drug Discovery
Ruth Nussinov, Chung‐Jung Tsai
Cell (2013) Vol. 153, Iss. 2, pp. 293-305
Open Access | Times Cited: 659
G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Sergi Ferré, Vicent Casadó, Lakshmi A. Devi, et al.
Pharmacological Reviews (2014) Vol. 66, Iss. 2, pp. 413-434
Open Access | Times Cited: 527
Relaxin Family Peptides and Their Receptors
Ross A. D. Bathgate, Michelle L. Halls, Emma T. van der Westhuizen, et al.
Physiological Reviews (2013) Vol. 93, Iss. 1, pp. 405-480
Closed Access | Times Cited: 498
Functional Selectivity and Biased Receptor Signaling
Terry Kenakin
Journal of Pharmacology and Experimental Therapeutics (2010) Vol. 336, Iss. 2, pp. 296-302
Closed Access | Times Cited: 487
Therapeutic potential of β-arrestin- and G protein-biased agonists
Erin J. Whalen, Sudarshan Rajagopal, Robert J. Lefkowitz
Trends in Molecular Medicine (2010) Vol. 17, Iss. 3, pp. 126-139
Open Access | Times Cited: 485
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Terry Kenakin, Christian Watson, Vanessa Muniz‐Medina, et al.
ACS Chemical Neuroscience (2011) Vol. 3, Iss. 3, pp. 193-203
Open Access | Times Cited: 470
Activation and Regulation of Purinergic P2X Receptor Channels
Claudio Coddou, Zonghe Yan, Tomáš Obšil, et al.
Pharmacological Reviews (2011) Vol. 63, Iss. 3, pp. 641-683
Open Access | Times Cited: 463
Phase-plate cryo-EM structure of a class B GPCR–G-protein complex
Yi-Lynn Liang, Maryam Khoshouei, Mazdak Radjainia, et al.
Nature (2017) Vol. 546, Iss. 7656, pp. 118-123
Open Access | Times Cited: 459
Emerging paradigms in GPCR allostery: implications for drug discovery
Denise Wootten, Arthur Christopoulos, Patrick M. Sexton
Nature Reviews Drug Discovery (2013) Vol. 12, Iss. 8, pp. 630-644
Closed Access | Times Cited: 445
Diversity and modularity of G protein-coupled receptor structures
Vsevolod Katritch, Vadim Cherezov, Raymond C. Stevens
Trends in Pharmacological Sciences (2011) Vol. 33, Iss. 1, pp. 17-27
Open Access | Times Cited: 432
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Sudarshan Rajagopal, Seungkirl Ahn, David H. Rominger, et al.
Molecular Pharmacology (2011) Vol. 80, Iss. 3, pp. 367-377
Open Access | Times Cited: 377
The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
Yuri K. Peterson, Louis M. Luttrell
Pharmacological Reviews (2017) Vol. 69, Iss. 3, pp. 256-297
Open Access | Times Cited: 376
Structure, function and pathophysiology of protease activated receptors
Mark N. Adams, Rithwik Ramachandran, Mei‐Kwan Yau, et al.
Pharmacology & Therapeutics (2011) Vol. 130, Iss. 3, pp. 248-282
Closed Access | Times Cited: 348
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes
Chris de Graaf, Dan Donnelly, Denise Wootten, et al.
Pharmacological Reviews (2016) Vol. 68, Iss. 4, pp. 954-1013
Open Access | Times Cited: 315
Fluorescence/Bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling
Martin J. Lohse, Susanne Nuber, Carsten Hoffmann
Pharmacological Reviews (2012) Vol. 64, Iss. 2, pp. 299-336
Closed Access | Times Cited: 297
Targeting proteinase-activated receptors: therapeutic potential and challenges
Rithwik Ramachandran, Farshid Noorbakhsh, Kathryn DeFea, et al.
Nature Reviews Drug Discovery (2012) Vol. 11, Iss. 1, pp. 69-86
Closed Access | Times Cited: 296
The delta opioid receptor: an evolving target for the treatment of brain disorders
Amynah Pradhan, Katia Befort, Chihiro Nozaki, et al.
Trends in Pharmacological Sciences (2011) Vol. 32, Iss. 10, pp. 581-590
Open Access | Times Cited: 282
Conformational selection or induced fit? 50 years of debate resolved
Jean‐Pierre Changeux, Stuart J. Edelstein
F1000 Biology Reports (2011) Vol. 3
Open Access | Times Cited: 260
Drugs for Allosteric Sites on Receptors
Cody J. Wenthur, Patrick R. Gentry, Thomas P. Mathews, et al.
The Annual Review of Pharmacology and Toxicology (2011) Vol. 54, Iss. 1, pp. 165-184
Open Access | Times Cited: 247
CB2Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
Amey Dhopeshwarkar, Ken Mackie
Molecular Pharmacology (2014) Vol. 86, Iss. 4, pp. 430-437
Open Access | Times Cited: 246
Page 1 - Next Page

Scroll to top